Wall Street Zen upgraded shares of United States Antimony (NYSE:UAMY – Free Report) from a strong sell rating to a sell rating in a report released on Saturday morning,Wall Street Zen reports.
A number of other research firms also recently issued reports on UAMY. Texas Capital upgraded shares of United States Antimony to a “strong-buy” rating in a research report on Wednesday, October 7th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of United States Antimony in a research report on Monday, September 14th. Finally, HC Wainwright cut their price target on United States Antimony from $9.25 to $6.50 and set a “buy” rating on the stock in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $8.75.
Get Our Latest Stock Report on United States Antimony
United States Antimony Price Performance
UAMY stock opened at $2.67 on Friday. The firm’s fifty day simple moving average is $3.72 and its 200-day simple moving average is $6.86. The company has a market capitalization of $398.87 million, a P/E ratio of -17.77 and a beta of 0.49. United States Antimony has a 12 month low of $2.53 and a 12 month high of $12.64.
United States Antimony (NYSE:UAMY – Get Free Report) last released its quarterly earnings data on Thursday, November 12th. The company reported ($0.06) earnings per share for the quarter. United States Antimony had a negative return on equity of 7.73% and a negative net margin of 55.44%. The business had revenue of $10.13 million during the quarter. As a group, sell-side analysts forecast that United States Antimony will post -0.01 earnings per share for the current year.
Insider Buying and Selling at United States Antimony
In other news, CEO Gary C. Evans bought 20,000 shares of the business’s stock in a transaction dated Friday, August 28th. The stock was purchased at an average cost of $4.92 per share, with a total value of $98,400.00. Following the acquisition, the chief executive officer directly owned 2,590,028 shares in the company, valued at $12,742,937.76. This trade represents a 0.78% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Joseph A. Carrabba bought 21,300 shares of the firm’s stock in a transaction that occurred on Tuesday, September 1st. The stock was purchased at an average price of $4.72 per share, with a total value of $100,536.00. Following the completion of the purchase, the director owned 198,401 shares in the company, valued at approximately $936,452.72. This trade represents a 12.03% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders purchased 62,700 shares of company stock valued at $298,592. 5.50% of the stock is owned by company insiders.
Institutional Trading of United States Antimony
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in shares of United States Antimony in the second quarter valued at about $82,365,000. Marshall Wace LLP increased its stake in shares of United States Antimony by 228.0% during the third quarter. Marshall Wace LLP now owns 3,954,186 shares of the company’s stock worth $16,489,000 after purchasing an additional 2,748,800 shares in the last quarter. Jump Financial LLC purchased a new stake in shares of United States Antimony during the third quarter worth about $2,640,000. Bank of America Corp DE purchased a new stake in shares of United States Antimony during the second quarter worth about $4,208,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of United States Antimony during the second quarter worth about $2,871,000. Institutional investors and hedge funds own 9.49% of the company’s stock.
About United States Antimony
United States Antimony Corporation mines, processes and sells antimony and related products. Its offerings include antimony oxide, antimony metal and sodium antimonate, materials used in a range of industrial applications. The company also produces zeolite through its Bear River Zeolite operations in Idaho. Zeolite products are used in applications such as water treatment, agriculture and odor control. Founded in 1968, United States Antimony has processing operations in Montana and Mexico, as well as zeolite operations in Idaho.
Further Reading
- Five stocks we like better than United States Antimony
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for United States Antimony Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United States Antimony and related companies with MarketBeat.com's FREE daily email newsletter.
